Vascular progenitor clusters from peripheral blood in cancer patients following oncologic surgery

Journal of Surgical Oncology

Volumn 109, Issue 2, 2014, Pages 151-157

  Javidnia, Hedyeh ^a   Hanna, Mary ^b   Li, Yuhua ^c   Scheer, Adena ^a   Filion, Lionel ^a   Eapen, Libni ^a   Carrier, Marc ^b   Auer, Rebecca ^a   Corsten, Martin ^a   Allan, David S ^a,b,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

angiogenesis; cancer; colorectal cancer; endothelial progenitors; oral cancer; surgery; vascular progenitors

Indexed keywords

CD34 ANTIGEN; VASCULOTROPIN RECEPTOR 2;

ADULT; ARTICLE; BLOOD VESSEL INJURY; CANCER GROWTH; CANCER PATIENT; CANCER SURGERY; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; CONVALESCENCE; FEMALE; FOLLOW UP; FREE TISSUE GRAFT; HEMICOLECTOMY; HUMAN; HUMAN CELL; LAPAROSCOPIC SURGERY; LAPAROTOMY; MALE; MIDDLE AGED; MOUTH CANCER; PRIORITY JOURNAL; PROCTOCOLECTOMY; RECTUM ANTERIOR RESECTION; STEM CELL; SURGICAL STRESS; TUMOR VOLUME; VASCULAR PROGENITOR CELL;

ANGIOGENESIS; CANCER; COLORECTAL CANCER; ENDOTHELIAL PROGENITORS; ORAL CANCER; SURGERY; VASCULAR PROGENITORS;

AGED; ANTIGENS, CD34; CELLS, CULTURED; COLORECTAL NEOPLASMS; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOVASCULARIZATION, PHYSIOLOGIC; POSTOPERATIVE PERIOD; STEM CELLS; SURGICAL FLAPS; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84892936865     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23468     Document Type: Article

References (37)

1. Rafii S, Lyden D:, Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003; 9: 702-712.
2. Lin Y, Weisdorf DJ, Solovey A, et al.: Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000; 105: 71-77.
3. Rabelink TJ, de Boer HC, de Koning EJ, et al.: Endothelial progenitor cells: More than an inflammatory response ? Arterioscle Thrombosis Vasc Biol 2004; 24: 834-838.
4. Barkan D, Green JE, Chambers AF:, Extracellular matrix: A gatekeeper in the transition from dormancy to metastatic growth. Eur J Cancer 2010; 46: 1181-1188.
5. Kaplan RN, Rafii S, Lyden D:, Preparing the "soil": The premetastatic niche. Cancer Res 2006; 66: 11089-11093.
6. Roberts N, Xiao Q, Weir G, et al.: Endothelial progenitor cells are mobilized after cardiac surgery. Ann Thorac Surg 2007; 83: 598-605.
7. Langenberg MH, Nijkamp MW, Roodhart JM, et al.: Liver surgery induces an immediate mobilization of progenitor cells in liver cancer patients: A potential role for G-CSF. Cancer Biol Ther 2010; 9: 743-748.
8. Schillaci G, Rondelli F, Pirro M, et al.: Endothelial progenitor cells are mobilized after major laparotomic surgery in patients with cancer. Int J Immunopathol Pharmacol 2009; 22: 1035-1041.
9. Hill JM, Zalos G, Halcox JP, et al.: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
10. Peichev M, Naiyer AJ, Pereira D, et al.: Expression of VEGFR-2 and AC133 by circulating human CD34 (+) cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952-958.
11. Asahara T, Murohara T, Sullivan A, et al.: Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
12. Rohde E, Malischnik C, Thaler D, et al.: Blood monocytes mimic endothelial progenitor cells. Stem Cells 2006; 24: 357-367.
13. Ubrich C, Heeschen C, Aicher A, et al.: Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 2003; 108: 2511-2516.
14. Shintani S, Murohara T, Ikeda H, et al.: Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001; 103: 2776-2779.
15. Assmus B, Schachinger V, Teupe C, et al.: Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002; 106: 3009-3017.
16. Ghani U, Shuaib A, Salam A, et al.: Endothelial progenitor cells during cerebrovascular disease. Stroke 2005; 36: 151-153.
17. Rafat N, Hanusch C, Brinkkoetter PT, et al.: Increased circulating endothelial progenitor cells in septic patients: Correlation with survival. Crit Care Med 2007; 35: 1677-1684.
18. Ahn JB, Rha SY, Shin SJ, et al.: Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients. Cancer Lett 2010; 288: 124-132.
19. Dome B, Timar J, Ostoros G, et al.: Endothelial progenitor cells in non-small cell lung cancer. J Clin Pathol 2005; 58: 447.
20. Ho JW, Pang RW, Lau C, et al.: Significance of circulating endothelial progenitor cells in hepatocellular carcinoma. Hepatology 2006; 44: 836-843.
21. Naik RP, Jin D, Chuang E, et al.: Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer. Breast Cancer Res Treat 2008; 107: 133-138.
22. Nolan DJ, Ciarrocchi A, Mellick AS, et al.: Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev 2007; 21: 1546-1558.
23. Gao D, Nolan D, McDonnell K, et al.: Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression. Biochim Biophys Acta 2009; 1796: 33-40.
24. Pirro M, Cagini L, Paciullo F, et al.: Baseline and post-surgery endothelial progenitor cell levels in patients with early-stage non-small-cell lung carcinoma: Impact on cancer recurrence and survival. Eur J Cardiothorac Surg 2013; 44: e245-e252.
25. National Cancer Institute Common Toxicity Criteria v3.0, available at http://ctep.info.nih.gov/CTC3/ctc.htm. Posted April 1, 2003.
26. Keeney M, Chin-Yee I, Weir K, et al.: Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering. Cytometry 1998; 34: 61-70.
27. Brunner M, Thurnher D, Heiduschka G, et al.: Elevated levels of circulating endothelial progenitor cells in head and neck cancer patients. J Surg Oncol 2008; 98: 545-550.
28. Real C, Remédio L, Caiado F, et al.: Bone marrow-derived endothelial progenitors expressing Delta-like 4 (Dll4) regulate tumor angiogenesis. PLoS ONE 2011; 6: e18323.
29. Allan DS, Morgan SC, Birch PE, et al.: Circulating vascular progenitors are mobilized in cancer patients receiving external beam radiation in response to tissue injury. Int J Rad Onc Biol Phys 2009; 75: 220-224.
30. Allan DS, Dube P, Roy J, et al.: Endothelial-like vascular progenitor cells (VPCs) from allogeneic and autologous donors: Mobilization features distinct from hematopoietic progenitors. Biol Blood Marrow Transplant 2007; 13: 433-439.
31. Benayou L, Gingis-Velitski S, Voloshin T, et al.: Tumor-initiating cells of various tumor types exhibit differential angiogenic properties and react differently to angiogenic drugs. Stem Cells 2012; 30: 1831-1841.
32. Bono A, Bianchi P, Locatelli A, et al.: Angiogenic cells, macroparticles and RNA transcripts in laparoscopic vs open surgery for colorectal cancer. Cancer Biol Ther 2010; 10: 682-685.
33. Kondo T, Hayashi M, Takeshita K, et al.: Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol 2004; 24: 1442-1447.
34. Paschalaki KE, Starke RD, Hu Y, et al.: Dysfunction of endothelial progenitor cells from smokers and COPD patients due to increased DNA damage and senescence. Stem Cells 2013; doi: 10.1002/stem.1488 [epub ahead of print 29 July 2013].
35. Gill M, Dias K, Hattori ML, et al.: Vascular trauma induces rapid but transient mobilization of VEGFR2 (+) AC133 (-) endothelial precursor cells. Circ Res 2001; 88: 167-174.
36. Takeomoto Y, Li TS, Kubo M, et al.: Operative injury accelerates tumor growth by inducing mobilization and recruitment of bone marrow-derived stem cells. Surgery 2011; 149: 792-800.
37. Beerepoot LV, Mehra N, Vermaat JS, et al.: Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients. Ann Oncol 2004; 15: 139-145.